Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$74.84
+0.9%
$66.10
$61.01
$91.07
$4.42B1.12427,075 shs411,283 shs
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$23.25
-0.4%
$23.17
$15.11
$25.41
$15.99B1.099.70 million shs9.44 million shs
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$6.38
-2.3%
$6.14
$2.33
$7.30
$1.88B1.173.84 million shs1.74 million shs
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$70.56
-1.1%
$73.55
$61.09
$76.97
$15.89B0.761.64 million shs1.64 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
+0.96%+3.82%+15.06%+17.57%+7.86%
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
-0.43%-6.70%-5.56%+21.79%+43.47%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-2.30%-5.20%+16.00%+39.61%+165.83%
W.P. Carey Inc. stock logo
WPC
W.P. Carey
-0.98%-3.87%-5.29%-0.39%+12.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$74.84
+0.9%
$66.10
$61.01
$91.07
$4.42B1.12427,075 shs411,283 shs
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$23.25
-0.4%
$23.17
$15.11
$25.41
$15.99B1.099.70 million shs9.44 million shs
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$6.38
-2.3%
$6.14
$2.33
$7.30
$1.88B1.173.84 million shs1.74 million shs
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$70.56
-1.1%
$73.55
$61.09
$76.97
$15.89B0.761.64 million shs1.64 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
+0.96%+3.82%+15.06%+17.57%+7.86%
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
-0.43%-6.70%-5.56%+21.79%+43.47%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-2.30%-5.20%+16.00%+39.61%+165.83%
W.P. Carey Inc. stock logo
WPC
W.P. Carey
-0.98%-3.87%-5.29%-0.39%+12.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
1.67
Reduce$85.0013.57% Upside
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
2.71
Moderate Buy$23.953.02% Upside
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.00
Buy$12.6297.73% Upside
W.P. Carey Inc. stock logo
WPC
W.P. Carey
2.38
Hold$77.8310.31% Upside

Current Analyst Ratings Breakdown

Latest HHH, TSHA, HST, and WPC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Reiterated RatingMarket Outperform$11.00
6/30/2026
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
DowngradeBuy (B)Buy (B-)
6/30/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Reiterated RatingBuy$12.00
6/30/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Boost Price TargetOutperform$12.00 ➝ $15.00
6/24/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Reiterated RatingSell (D-)
6/23/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Set Price Target$14.00
6/23/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Boost Price TargetOutperform$10.00 ➝ $14.00
6/23/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Reiterated RatingOutperform
6/23/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Boost Price TargetMarket Outperform$8.00 ➝ $11.00
6/22/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Boost Price TargetBuy$9.00 ➝ $10.00
6/22/2026
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
UpgradeStrong SellHold
(Data available from 7/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$1.47B3.03$6.26 per share11.96$49.69 per share1.51
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$6.11B2.60$2.27 per share10.22$9.54 per share2.44
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$9.77M187.65N/AN/A$0.90 per share7.09
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$1.72B9.16$4.56 per share15.48$37.12 per share1.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$131.88M$2.0427.4921.95N/A8.04%5.41%1.61%N/A
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$765M$1.4715.8210.762.6416.40%15.15%7.75%8/5/2026 (Estimated)
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$109M-$0.38N/AN/AN/AN/A-56.07%-40.16%8/11/2026 (Estimated)
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$466.36M$2.3430.1513.442.7629.35%6.29%2.86%8/4/2026 (Estimated)

Latest HHH, TSHA, HST, and WPC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$0.08$0.14+$0.06$0.14N/A$235.92 million
5/6/2026Q1 2026
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$0.3575$0.67+$0.3125$0.72$1.59 billion$1.65 billion
5/6/2026Q1 2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$0.10-$0.12-$0.02-$0.12$0.76 millionN/A
4/28/2026Q1 2026
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$0.6080$1.30+$0.6920$0.80$430.64 million$454.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
N/AN/AN/AN/AN/A
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
$0.803.44%+36.56%54.42%2 Years
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
N/AN/AN/AN/AN/A
W.P. Carey Inc. stock logo
WPC
W.P. Carey
$3.765.33%-2.79%160.68%2 Years

Latest HHH, TSHA, HST, and WPC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2026
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
quarterly$0.203.37%6/30/20266/30/20267/15/2026
6/11/2026
W.P. Carey Inc. stock logo
WPC
W.P. Carey
quarterly$0.945.26%6/30/20266/30/20267/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
1.97
1.58
1.58
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
0.74
7.91
7.91
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
0.23
14.04
14.04
W.P. Carey Inc. stock logo
WPC
W.P. Carey
1.04
0.35
0.35

Institutional Ownership

CompanyInstitutional Ownership
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
93.83%
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
98.52%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
77.70%
W.P. Carey Inc. stock logo
WPC
W.P. Carey
73.73%

Insider Ownership

CompanyInsider Ownership
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
48.00%
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
1.50%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.78%
W.P. Carey Inc. stock logo
WPC
W.P. Carey
0.98%
CompanyEmployeesShares OutstandingFree FloatOptionable
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
60859.62 million31.01 millionOptionable
Host Hotels & Resorts, Inc. stock logo
HST
Host Hotels & Resorts
160684.88 million674.61 millionOptionable
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
180287.36 million276.50 millionOptionable
W.P. Carey Inc. stock logo
WPC
W.P. Carey
190222.74 million220.56 millionOptionable

Recent News About These Companies

W. P. Carey Releases 2025 Corporate Responsibility Report
W.P. Carey Inc. $WPC Shares Bought by Hsbc Holdings PLC
W. P. Carey tenant Hellweg files for insolvency

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Howard Hughes stock logo

Howard Hughes NYSE:HHH

$74.84 +0.63 (+0.85%)
Closing price 07/6/2026 03:59 PM Eastern
Extended Trading
$74.70 -0.14 (-0.18%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Howard Hughes Holdings Inc., together with its subsidiaries, operates as a real estate development company in the United States. It operates in four segments: Operating Assets; Master Planned Communities (MPCs); Seaport; and Strategic Developments. The Operating Assets segment consists of developed or acquired retail, office, and multi-family properties along with other retail investments. Its MPCs segment develops, sells, and leases residential and commercial land designated for long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. The Seaport segment is involved in the landlord operations, managed businesses, and events and sponsorships services of its restaurant, retail, and entertain properties in Pier 17, New York City; Historic Area/Uplands; and Tin Building, as well as in 250 Water Street and in the Jean-Georges restaurants. The Strategic Development segment develops and redevelops residential condominiums and commercial properties. It serves homebuilders. Howard Hughes Holdings Inc. was founded in 2010 and is headquartered in The Woodlands, Texas.

Host Hotels & Resorts stock logo

Host Hotels & Resorts NASDAQ:HST

$23.25 -0.10 (-0.43%)
Closing price 07/6/2026 04:00 PM Eastern
Extended Trading
$23.16 -0.09 (-0.37%)
As of 04:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Host Hotels & Resorts, Inc. is a real estate investment trust, which engages in the management of luxury and upper-upscale hotels. It operates through the following geographical segments: United States, Brazil, and Canada. The company was founded in 1927 and is headquartered in Bethesda, MD.

Taysha Gene Therapies stock logo

Taysha Gene Therapies NASDAQ:TSHA

$6.38 -0.15 (-2.30%)
Closing price 07/6/2026 04:00 PM Eastern
Extended Trading
$6.25 -0.13 (-2.10%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

W.P. Carey stock logo

W.P. Carey NYSE:WPC

$70.56 -0.76 (-1.07%)
Closing price 07/6/2026 03:59 PM Eastern
Extended Trading
$70.47 -0.09 (-0.13%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

W. P. Carey ranks among the largest net lease REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate, which includes 1,424 net lease properties covering approximately 173 million square feet and a portfolio of 89 self-storage operating properties as of December 31, 2023. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Northern and Western Europe, under long-term net leases with built-in rent escalations.